Literature DB >> 17037579

Animal models for SARS.

Anjeanette Roberts1, Kanta Subbarao.   

Abstract

Entities:  

Mesh：

Year:  2006        PMID： 17037579      PMCID： PMC7123016          DOI： 10.1007/978-0-387-33012-9_83

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN： 0065-2598            Impact factor:   2.622


× No keyword cloud information.
  25 in total

1.  Aged BALB/c mice as a model for increased severity of severe acute respiratory syndrome in elderly humans.

Authors:  Anjeanette Roberts; Christopher Paddock; Leatrice Vogel; Emily Butler; Sherif Zaki; Kanta Subbarao
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

2.  Prior infection and passive transfer of neutralizing antibody prevent replication of severe acute respiratory syndrome coronavirus in the respiratory tract of mice.

Authors:  Kanta Subbarao; Josephine McAuliffe; Leatrice Vogel; Gary Fahle; Steven Fischer; Kathleen Tatti; Michelle Packard; Wun-Ju Shieh; Sherif Zaki; Brian Murphy
Journal:  J Virol       Date:  2004-04       Impact factor: 5.103

3.  Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China.

Authors:  Y Guan; B J Zheng; Y Q He; X L Liu; Z X Zhuang; C L Cheung; S W Luo; P H Li; L J Zhang; Y J Guan; K M Butt; K L Wong; K W Chan; W Lim; K F Shortridge; K Y Yuen; J S M Peiris; L L M Poon
Journal:  Science       Date:  2003-09-04       Impact factor: 47.728

4.  Pneumonitis and multi-organ system disease in common marmosets (Callithrix jacchus) infected with the severe acute respiratory syndrome-associated coronavirus.

Authors:  Thomas C Greenough; Angela Carville; James Coderre; Mohan Somasundaran; John L Sullivan; Katherine Luzuriaga; Keith Mansfield
Journal:  Am J Pathol       Date:  2005-08       Impact factor: 4.307

5.  Therapy with a severe acute respiratory syndrome-associated coronavirus-neutralizing human monoclonal antibody reduces disease severity and viral burden in golden Syrian hamsters.

Authors:  Anjeanette Roberts; William D Thomas; Jeannette Guarner; Elaine W Lamirande; Gregory J Babcock; Thomas C Greenough; Leatrice Vogel; Norman Hayes; John L Sullivan; Sherif Zaki; Kanta Subbarao; Donna M Ambrosino
Journal:  J Infect Dis       Date:  2006-01-27       Impact factor: 5.226

6.  Development and characterization of a severe acute respiratory syndrome-associated coronavirus-neutralizing human monoclonal antibody that provides effective immunoprophylaxis in mice.

Authors:  Thomas C Greenough; Gregory J Babcock; Anjeanette Roberts; Hector J Hernandez; William D Thomas; Jennifer A Coccia; Robert F Graziano; Mohan Srinivasan; Israel Lowy; Robert W Finberg; Kanta Subbarao; Leatrice Vogel; Mohan Somasundaran; Katherine Luzuriaga; John L Sullivan; Donna M Ambrosino
Journal:  J Infect Dis       Date:  2005-01-14       Impact factor: 5.226

7.  A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice.

Authors:  Zhi-Yong Yang; Wing-Pui Kong; Yue Huang; Anjeanette Roberts; Brian R Murphy; Kanta Subbarao; Gary J Nabel
Journal:  Nature       Date:  2004-04-01       Impact factor: 49.962

8.  Human monoclonal antibody as prophylaxis for SARS coronavirus infection in ferrets.

Authors:  Jan ter Meulen; Alexander B H Bakker; Edward N van den Brink; Gerrit J Weverling; Byron E E Martina; Bart L Haagmans; Thijs Kuiken; John de Kruif; Wolfgang Preiser; Willy Spaan; Hans R Gelderblom; Jaap Goudsmit; Albert D M E Osterhaus
Journal:  Lancet       Date:  2004-06-26       Impact factor: 79.321

9.  Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome.

Authors:  Thijs Kuiken; Ron A M Fouchier; Martin Schutten; Guus F Rimmelzwaan; Geert van Amerongen; Debby van Riel; Jon D Laman; Ton de Jong; Gerard van Doornum; Wilina Lim; Ai Ee Ling; Paul K S Chan; John S Tam; Maria C Zambon; Robin Gopal; Christian Drosten; Sylvie van der Werf; Nicolas Escriou; Jean-Claude Manuguerra; Klaus Stöhr; J S Malik Peiris; Albert D M E Osterhaus
Journal:  Lancet       Date:  2003-07-26       Impact factor: 79.321

10.  An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus.

Authors:  Elisabetta Traggiai; Stephan Becker; Kanta Subbarao; Larissa Kolesnikova; Yasushi Uematsu; Maria Rita Gismondo; Brian R Murphy; Rino Rappuoli; Antonio Lanzavecchia
Journal:  Nat Med       Date:  2004-07-11       Impact factor: 53.440
View more
  13 in total

Review 1.  The battle against SARS and MERS coronaviruses: Reservoirs and Animal Models.

Authors:  Shu-Ran Gong; Lin-Lin Bao
Journal:  Animal Model Exp Med       Date:  2018-07-28

2.  Successful vaccination strategies that protect aged mice from lethal challenge from influenza virus and heterologous severe acute respiratory syndrome coronavirus.

Authors:  Timothy Sheahan; Alan Whitmore; Kristin Long; Martin Ferris; Barry Rockx; William Funkhouser; Eric Donaldson; Lisa Gralinski; Martha Collier; Mark Heise; Nancy Davis; Robert Johnston; Ralph S Baric
Journal:  J Virol       Date:  2010-10-27       Impact factor: 5.103

3.  Differential virological and immunological outcome of severe acute respiratory syndrome coronavirus infection in susceptible and resistant transgenic mice expressing human angiotensin-converting enzyme 2.

Authors:  Naoko Yoshikawa; Tomoki Yoshikawa; Terence Hill; Cheng Huang; Douglas M Watts; Shinji Makino; Gregg Milligan; Tehsheng Chan; Clarence J Peters; Chien-Te K Tseng
Journal:  J Virol       Date:  2009-03-18       Impact factor: 5.103

4.  Mechanisms of zoonotic severe acute respiratory syndrome coronavirus host range expansion in human airway epithelium.

Authors:  Timothy Sheahan; Barry Rockx; Eric Donaldson; Amy Sims; Raymond Pickles; Davide Corti; Ralph Baric
Journal:  J Virol       Date:  2007-12-19       Impact factor: 5.103

Review 5.  Development of animal models against emerging coronaviruses: From SARS to MERS coronavirus.

Authors:  Troy C Sutton; Kanta Subbarao
Journal:  Virology       Date:  2015-03-16       Impact factor: 3.616

Review 6.  SARS-CoV-2 pandemic and research gaps: Understanding SARS-CoV-2 interaction with the ACE2 receptor and implications for therapy.

Authors:  Prasun K Datta; Fengming Liu; Tracy Fischer; Jay Rappaport; Xuebin Qin
Journal:  Theranostics       Date:  2020-06-12       Impact factor: 11.556

7.  A new mouse-adapted strain of SARS-CoV as a lethal model for evaluating antiviral agents in vitro and in vivo.

Authors:  Craig W Day; Ralph Baric; Sui Xiong Cai; Matt Frieman; Yohichi Kumaki; John D Morrey; Donald F Smee; Dale L Barnard
Journal:  Virology       Date:  2009-10-22       Impact factor: 3.616

Review 8.  Animal models for SARS-CoV-2 research: A comprehensive literature review.

Authors:  Kabita Pandey; Arpan Acharya; Mahesh Mohan; Caroline L Ng; St Patrick Reid; Siddappa N Byrareddy
Journal:  Transbound Emerg Dis       Date:  2020-12-20       Impact factor: 5.005

Review 9.  From SARS to MERS, Thrusting Coronaviruses into the Spotlight.

Authors:  Zhiqi Song; Yanfeng Xu; Linlin Bao; Ling Zhang; Pin Yu; Yajin Qu; Hua Zhu; Wenjie Zhao; Yunlin Han; Chuan Qin
Journal:  Viruses       Date:  2019-01-14       Impact factor: 5.048

10.  Cloning, expression and immunoassay detection of ferret IFN-gamma.

Authors:  Atsuo Ochi; Ali Danesh; Charit Seneviratne; David Banner; Mark E Devries; Thomas Rowe; Luoling Xu; Longsi Ran; Markus Czub; Steven E Bosinger; Mark J Cameron; Cheryl M Cameron; David J Kelvin
Journal:  Dev Comp Immunol       Date:  2008-01-28       Impact factor: 3.636
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.